Synthetic lethality-based predictive biomarker identification of splicing modulators in lung cancer

被引：0
|
作者：
Repellin, Claire E. [1 ]
Patel, Puja [1 ]
Shi, Yihui [1 ]
Gong, Helena [1 ]
Webb, Thomas R. [1 ]
Sambucetti, Lidia [1 ]
Sinha, Subarna [1 ]
机构：
[1] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4015
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Synthetic Lethality-based Targets for Discovery of New Cancer Therapeutics
    Weidle, Ulrich H.
    Maisel, Daniela
    Eick, Dirk
    CANCER GENOMICS & PROTEOMICS, 2011, 8 (04) : 159 - 171
  • [2] Synthetic Lethality-Based Therapeutics: Perspectives for Applications in Colorectal Cancer
    Soncini, D.
    Caffa, I.
    Patrone, F.
    Ballestrero, A.
    Nencioni, A.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (04) : 329 - 338
  • [3] Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network
    Liu, Lei
    Chen, Xiujie
    Hu, Chunyu
    Zhang, Denan
    Shao, Zhuo
    Jin, Qing
    Yang, Jingbo
    Xie, Hongbo
    Liu, Bo
    Hu, Ming
    Ke, Kehui
    SCIENTIFIC REPORTS, 2018, 8
  • [4] Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network
    Lei Liu
    Xiujie Chen
    Chunyu Hu
    Denan Zhang
    Zhuo Shao
    Qing Jin
    Jingbo Yang
    Hongbo Xie
    Bo Liu
    Ming Hu
    Kehui Ke
    Scientific Reports, 8
  • [5] Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies
    Bajpai, Richa
    Shanmugam, Mala
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (05) : 338 - 344
  • [6] MTAP deletion and synthetic lethality-based drug development for metastatic breast cancer (MBC)
    Pusztai, Lajos
    Danziger, Natalie
    Sokol, Ethan S.
    Pavlick, Dean C.
    Graf, Ryon
    Ramkissoon, Shakti
    Huang, Richard S. P.
    Decker, Brennan J.
    Ross, Jeffrey S.
    CANCER RESEARCH, 2022, 82 (04)
  • [7] Loss of heterozygosity exploited for collateral lethality-based cancer therapy
    Fang, Hai
    EBIOMEDICINE, 2024, 109
  • [8] An interpretable artificial intelligence framework for designing synthetic lethality-based anti-cancer combination therapies
    Wang, Jing
    Wen, Yuqi
    Zhang, Yixin
    Wang, Zhongming
    Jiang, Yuyang
    Dai, Chong
    Wu, Lianlian
    Leng, Dongjin
    He, Song
    Bo, Xiaochen
    JOURNAL OF ADVANCED RESEARCH, 2024, 65 : 329 - 343
  • [9] Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
    Pal, Lipika R.
    Cheng, Kuoyuan
    Nair, Nishanth Ulhas
    Martin-Sancho, Laura
    Sinha, Sanju
    Pu, Yuan
    Riva, Laura
    Yin, Xin
    Schischlik, Fiorella
    Lee, Joo Sang
    Chanda, Sumit K.
    Ruppin, Eytan
    ISCIENCE, 2022, 25 (05)
  • [10] RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
    Toma, Monika
    Sullivan-Reed, Katherine
    Sliwinski, Tomasz
    Skorski, Tomasz
    CANCERS, 2019, 11 (10)
12345